Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 376 AL 390

Cryo-EM structures of tau filaments

Scheres SH, Zhang W, Falcon B, Goedert M.

Curr Opin Struct Biol. 2020 Oct;64:17-25. doi: 10.1016/j.sbi.2020.05.011. Epub 2020 Jun 27.

Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease

Sharma V, Kaur A, Singh TG.

Biomed Pharmacother. 2020 Sep;129:110373. doi: 10.1016/j.biopha.2020.110373. Epub 2020 Jun 27.

Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Int J Mol Sci. 2020 Jun 28;21(13):4599. doi: 10.3390/ijms21134599.

Pharmacological Treatment of Alzheimer's Disease: Insights from Drosophila melanogaster

Cheng X, Song C, Du Y, Gaur U, Yang M.

Int J Mol Sci. 2020 Jun 29;21(13):4621. doi: 10.3390/ijms21134621.

Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers

Guzmán-Vélez E, Martínez J, Papp K, Baena A, Vila-Castelar C, Artola A, Schultz AP, Bocanegra Y, Sanchez J, Rentz D, Tariot PN, Reiman EM, Sperling R, Johnson KA, Lopera F, Quiroz YT.

Neurology. 2020 Sep 8;95(10):e1312-e1321. doi: 10.1212/WNL.0000000000010177. Epub 2020 Jul 1.

Management of the early stage of Alzheimer's disease: a systematic review of literature over the past 10 years

Cocchiara RA, De Lucia F, Koci L, Lisanti E, Petruccini G, La Torre G.

Clin Ter. 2020 Jul-Aug;171(4):e357-e368. doi: 10.7417/CT.2020.2239.

The substrate repertoire of γ-secretase/presenilin

Güner G, Lichtenthaler SF.

Semin Cell Dev Biol. 2020 Sep;105:27-42. doi: 10.1016/j.semcdb.2020.05.019. Epub 2020 Jun 29.

Cancer and Alzheimer's disease: intracellular pH scales the metabolic disorders

Schwartz L, Peres S, Jolicoeur M, da Veiga Moreira J.

Biogerontology. 2020 Dec;21(6):683-694. doi: 10.1007/s10522-020-09888-6. Epub 2020 Jul 2.

New Approaches to Develop Drug Treatment for Alzheimer's Disease: Targeting Calcium Dysregulation

Wei H.

Curr Alzheimer Res. 2020;17(4):311-312. doi: 10.2174/156720501704200520094610.

Half a century of amyloids: past, present and future

Ke PC , Zhou R , Serpell LC , Riek R , Knowles TPJ , Lashuel HA , Gazit E , Hamley IW , Davis TP , Fändrich M , Otzen DE , Chapman MR , Dobson CM , Eisenberg DS , Mezzenga R .

Chem Soc Rev. 2020 Aug 7;49(15):5473-5509. doi: 10.1039/c9cs00199a. Epub 2020 Jul 7.

Recent advances in tau-directed immunotherapy against Alzheimer's disease: an overview of pre-clinical and clinical development

Ng PY, Chang IS, Koh RY, Chye SM.

Metab Brain Dis. 2020 Oct;35(7):1049-1066. doi: 10.1007/s11011-020-00591-6. Epub 2020 Jul 6.

Preventive Role of L-Carnitine and Balanced Diet in Alzheimer's Disease

Kepka A, Ochocinska A, Borzym-Kluczyk M, Skorupa E, Stasiewicz-Jarocka B, Chojnowska S, Waszkiewicz N.

Nutrients. 2020 Jul 3;12(7):1987. doi: 10.3390/nu12071987.

Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β-Modifications: A Systematic Study

Farkhondeh T, Khan H, Aschner M, Samini F, Pourbagher-Shahri AM, Aramjoo H, Roshanravan B, Hoyte C, Mehrpour O, Samarghandian S.

CNS Neurol Disord Drug Targets. 2020;19(5):334-343. doi: 10.2174/1871527319666200708130745.

Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps

Kumar R, Gulati M, Singh SK, Sharma D, Porwal O.

CNS Neurol Disord Drug Targets. 2020;19(9):663-675. doi: 10.2174/1871527319666200708124726.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias